Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory disease that affects the apocrine glands in the axillary, groin, and breast regions, with apparent physiological and psychosocial sequelae. As many studies have reported, surgical management is one of the treatment options. A comprehensive systematic review of surgical treatment for HS is provided in this study. Literature retrieval was conducted on MEDLINE, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), China National Knowledge Infrastructure (CNKI) and clinical registries from their inception to 1 May 2022. The principles of the PRISMA were adhered to in the process of literature search and the reference lists of the articles retrieved were also checked for further reference. Heterogeneity was assessed in meta‐analysis by means of the Q‐test and I 2 index. A total of 13 studies were finally included which involved 535 participants in total. The average estimated complication rate was 11.1% (95% confidence interval [CI], 6.4%–16.9%). The meta‐analysis was conducted on pooled complication sample studies and pooled recurrence sample studies. The recurrence was 16.2% (95% CI, 9.1%–24.9%). Subgroup analysis revealed significant differences in HS complications among different closure types. Among different locations, the highest rate of 16.0% (95% CI, 6.8%–28.2%) was multiple locations. Besides, differences were also observed in diverse excision methods and the highest was deroofing 13.9% (95% CI, 2.2%–33.2%). Extensive resection, using skin flaps or skin grafts as a closure method, was associated with a higher incidence of complications. Providers should consider carefully the use of extensive resection or using skin flaps or skin grafts as a closure method so as to minimise the risk of adverse events.
Keywords: a systematic review, complications, hidradenitis suppurativa, meta‐analysis, surgical management
1. INTRODUCTION
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that mainly affects body areas abundant with apocrine glands, such as the axillae, groin, and the breasts, with obvious physiological and psychosocial sequelae. HS has a high recurrence rate even after an extensive surgical resection, and challenging reconstruction is associated with the risk of postoperative complications. 1 Clinical manifestations of HS include a single follicular nodule, deep skin abscesses, interconnected drainage sinus tracts, and hypertrophic scars. Persistent inflammation may lead to fibrosis, contracture, scarring, and significant change over time in incidence rate. Affected sites include the armpit (the most common site), groin, perianal, perineum, buttocks, inner thigh, breast, axilla, pubis, scrotum, vulva, chest, scalp, and retro auricular area. 2
HS is relatively common, with a prevalence of 0.05%‐4.10%, but many patients receive inadequate treatment. 3 The treatment of HS constitutes a challenge to doctors, as its pathogenesis is unclear, and the development and implementation of targeted therapy are hindered. 4 However, genetic susceptibility, environmental issues, such as smoking and obesity, endocrine causes, and micro‐biological factors are the potential influences. 5 The diagnosis of HS is mainly based on clinic, topographic and morphologic evidence, and chronic lesion as well. Sometimes, skin biopsy, bacterial culture, or imaging may be required to rule out other possibilities. 6 HS phenotypic heterogeneity is reflected in different classification systems, and its predictive effectiveness is associated with clinical characteristics. 5 Despite some controversy, various surgical treatments of HS have achieved varying degrees of success.
Surgical treatments include incisions and drainage, roof removal, and local and extensive resection. The healing options after extensive surgical resection include primary suture, secondary wound healing, skin flaps and grafts. It is reported that surgical resection of affected skin tissue with a sufficiently wide margin can successfully prevent complications, especially in the late stage. 7 , 8 Various factors should be considered when choosing surgical resection method and healing pathway, including the size and location of the lesion and patient characteristics. 9 In this study, the incidence of complications to specific reconstruction surgery was assessed and patients with secondary healing intentions were excluded. In addition, the evaluation of complications after initial laser resection of abnormal HS tissue is beyond the scope of this review.
The purpose of this systematic review and meta‐analysis was to choose the surgery and compared the postoperative complications. Secondary outcomes included differences in recurrence rate of these complications.
2. METHODS
2.1. Systematic literature search
This study was conducted under the guidance of Preferred Reporting Items for Systematic reviews and Meta‐Analysis protocols (PRISMA). 10 A systematic literature search was carried out in MEDLINE, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), China National Knowledge Infrastructure (CNKI) and clinical registries from their inception up to 1 May 2022. The reference list of the articles retrieved was also checked for further reference. Different combinations of keywords searched, including “hidradenitis suppurativa” or “Verneuil disease” or “acne inverse” and “surgery.” The two authors carried out systematic search and data extraction. It should be noted that when multiple studies reported findings on overlapping data sets, only those that reported results on recent data sets were included. Reviews, case reports, protocols, short communications, personal opinions, letters, posters, conference abstracts, laboratory studies, and reports on insufficient data were excluded. Studies dealing with the prevalence of HS in special populations were also considered in this study. After qualified studies were identified, their reference lists were also checked to obtain suitable studies for inclusion.
2.2. Data extraction
For each qualified article, the following items were extracted if available: author, year of study, study design, patient gender, excision location and type, closure type, the average duration of the lesion before surgery, and duration of follow‐up. If the number of events (ie, complications) was reported, the proportion was calculated by dividing the number of events by the sample size, and the perioperative closure‐related complication rates were calculated if applicable.
2.3. Statistical analysis
R software (version 4.1.3) was used for statistical analysis. Outcomes were pooled after Freeman‐Tukey double arcsine transformation using meta‐analysis. To adjust for the occurrence of zero events, a continuity correction of 0.5 was added to studies with zero events. Heterogeneity between studies was assessed with Cochran's Q and I 2 statistic. If heterogeneity was not present when the P‐value was higher than .1 in the Q‐test or the I 2 statistic was below than 50%, then the fixed‐effect model was adopted for analysis; otherwise, a random‐effect model was used. Publication bias was assessed using the Egger test and funnel plots.
3. RESULTS
3.1. Literature selection process
A total of 775 records were obtained after literature search, among which 627 records were screened by title and abstract, full‐text screening was conducted on 76 records. Thirteen studies were finally included for analysis 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 with 535 participants being involved (Table 1). Details about the screening process and the characteristics of the included studies were given in Figure 1.
TABLE 1.
Included studies
| Study ID | Country | Sample size | Duration before surgery (years) | Mean age (years) | Male (%) | Female (%) | Location | Excision method | Closure type | Adverse events |
|---|---|---|---|---|---|---|---|---|---|---|
| Soldin et al (2000) | South Africa and the United Kingdom | 68 | 3.5 | 32 | 31.48 | 68.52 | Axilla | Wide | Multiple | Recurrent disease |
| Rompel and Petres (2000) | Germany | 106 | 7 | 33.6 | 42.45 | 57.55 | Multiple | Wide | Multiple | Suture dehiscence, postoperative bleeding, and hematoma |
| Kuo and Ohara (2003) | Japan | 6 | 7.2 | 32.7 | 66.67 | 33.33 | Perianal | Wide | Graft | Graft necrosis and wound infection |
| Civelek et al (2010) | Turkey | 14 | — | — | — | — | Axilla | Wide | Multiple | Limited arm movement |
| van der Zee et al (2010) | The Netherlands | 44 | 7 | 35 | 6.82 | 93.18 | Multiple | Deroofing | Primary | Postoperative bleeding |
| Buyukasik et al (2011) | Turkey | 15 | 10 | 41.8 | 73.33 | 26.67 | Multiple | Wide | Multiple | Perineal, perianal, and buttocks sites |
| Liu et al (2011) | China | 12 | 5.5 | 45.3 | 92 | 8 | Multiple | Deroofing | Primary | Scar |
| Zhang et al (2014) | China | 6 | — | 25.2 | 16.67 | 83.33 | Axilla | Wide | Graft | Cutaneous necrosis |
| Blok et al (2015) | The Netherlands | 113 | 12 | 23.1 | 31.86 | 68.14 | Multiple | Deroofing | Primary | Hypergranulation of the wound |
| Chen et al (2016) | China | 50 | — | 36.4 | 88 | 12 | Perianal | Wide | Multiple | Wound infection |
| Chai et al (2018) | China | 6 | 5.3 | 23 | 83.33 | 16.67 | Multiple | Wide | Multiple | Serious infection |
| Hou et al (2019) | China | 15 | 9.3 | 53.3 | 94 | 6 | Multiple | Local | Graft | Tissue defects |
| Du et al (2021) | China | 70 | 3.3 | 34.5 | 70 | 30 | Perianal | Wide | Primary | Cutaneous necrosis |
FIGURE 1.

Flow diagram. CENTRAL, Cochrane Central Register of Controlled Trials; CNKI, China National Knowledge Infrastructure
3.2. Meta‐analysis
Figure 2 shows the forest plot of the overall complication rates. The average estimated complication rate was 11.1% (95% confidence interval [CI], 6.4%–16.9%). As shown in Figure 3, the overall HS recurrence was found to be 16.2% (95% CI, 9.1%–24.9%). Subgroup analysis revealed that significant differences in HS complications were not among different closure types. The highest complication rate was 18.9% (95% CI, 7.3%–34.3%) of skin graft, followed by that of multiple closures of 10.9% (4.9%–19.0%). This association should be interpreted with caution due to different surgery locations on different patients. Besides, differences in complication rate also existed among diverse excision methods with the highest of 13.9% (95% CI, 2.2%–33.2%) in deroofing. There was strong statistical evidence of heterogeneity (P < .05) which probably reflects the varying efficacy of the comparator regimens used in the trials. Table 2 shows the moderators of complications of HS which include multiple locations, 16.0% (95% CI, 6.8%–28.2%); deroofing, 13.9% (95% CI, 2.2%–33.2%); wide excision, 10.6% (95% CI, 5.2%–17.7%); multiple closures, 10.9% (95% CI, 4.9%–19.0%) and primary closure, 9.4% (95% CI, 2.2%–20.8%). Heterogeneity may also reflect the differences. As shown by Figure 4, both sides of the funnel plot were approximately symmetrical. Egger's test results (P = .1482 > .05) further confirmed that there was no publication bias in this meta‐analysis (Figure 5).
FIGURE 2.

Pooled complications of hidradenitis suppurativa
FIGURE 3.

Pooled recurrence of hidradenitis suppurativa
TABLE 2.
Subgroup analysis exhibiting moderators of complications of hidradenitis suppurativa
| Pooled complications of hidradenitis suppurativa undergoing surgery | ||||
|---|---|---|---|---|
| Group | No. of studies | Prevalence with 95% CI | P value for heterogeneity | I 2 value (%) |
| Location | ||||
| Axilla | 3 | 9.7% (1.4%–24.2%) | .09 | 58 |
| Mixed | 2 | 14.3% (3.0%–32.0%) | .85 | 0 |
| Multiple | 5 | 16.0% (6.8%–28.2%) | <.01 | 81 |
| Perianal | 3 | 4.5% (1.6%–8.7%) | .41 | 0 |
| Excision type | ||||
| Deroofing | 3 | 13.9% (2.2%–33.2%) | <.01 | 85 |
| Local | 1 | 13.3% (1.5%–34.4%) | Not applicable | Not applicable |
| Wide | 9 | 10.6% (5.2%–17.7%) | <.01 | 65 |
| Closure type | ||||
| Graft | 3 | 18.9% (7.3%–34.3%) | .59 | 0 |
| Multiple | 6 | 10.9% (4.9%–19.0%) | .02 | 62 |
| Primary | 3 | 9.4% (2.2%–20.8%) | <.01 | 81 |
Note: Multiple (location): including Axilla, perianal and gluteal. Multiple (closure type): including graft, flap and primary.
Abbreviation: CI, confidence interval.
FIGURE 4.

Funnel plot of overall complications for all studies
FIGURE 5.

Egger plot of overall complications for all studies
4. DISCUSSION
This systematic review and meta‐analysis of 13 studies (n = 535) demonstrated that surgical resection is perhaps the most effective treatment of severe or advanced HS. 24 There are many surgery options for HS, including incision and drainage, depilation and bagging, and local resection of localised or extensive margins. However, the best surgical technique and timing of HS still remain controversial. Our study attempts to explore the incidence of complications after such surgical management of varied lesion locations, excision methods, and closure types. This review is innovative in the following aspects: the principles of PRISMA were adopted, the reference lists of retrieved articles were checked for further reference, heterogeneity in meta‐analysis was tested by means of the Q‐test and I 2 statistic, and no publication bias was found in this meta‐analysis.
The current meta‐analysis showed a high prevalence of postoperative complications. The results of this review are consistent with that of previous studies concerning the impact of the surgery location, degree of involvement, and comorbidity upon the clinical outcomes. 25 , 26 , 27 As far as we are concerned, our review is the first to evaluate rates of postoperative complications after surgical treatment of HS, which should be carefully considered when deciding whether to initiate surgical treatment for HS. Furthermore, the present review also suggests that reconstruction after extensive resection exerts most significant impact on the incidence of complications, followed by differences in lesion locations.
As reported by relevant literature, there are various surgical techniques ranging from minimally invasive interventions to large skin flaps. Despite the variety of surgical methods, no consensus has been reached on the most preferred surgical option. A previous study found that 18% of the patients developed complications after wide surgical excision, suggesting that surgery with wide excision is accompanied by high rate of complications. 12 Besides, there are studies proposing that the risk of complications at the perianal region is the lowest 20 , 23 and that high complication rate results from the closure type of skin graft. 13 Indeed, there are large variations in clinical manifestations as reviewed in retrospective studies, and the lack of standardised surgical techniques makes the comparative evaluation of HS complications quite complicated.
This systematic review suffers from several limitations, including variable follow‐up time between studies, different types of surgery, variations in severity or duration of preoperative HS, surgical area (ie, axillary, inguinal, perianal, etc.), and lack of standardised outcome evaluation methods. Other potential sources of heterogeneity in each treatment group are related to the number of operations, simultaneous treatment, and operation time sequence, etc. Therefore, caution should be paid when directly comparing the results of different surgical techniques and the probability of subsequent complications. In addition, the possibility of postoperative functional damage should be considered when choosing one operation over another.
To sum up, this review identified risk factors of postoperative HS complications regarding varied lesion locations, excision methods, and closure types, which allow providers to engage in shared decision‐making with patients in regard to the potential risks and benefits. Future research is recommended to assess the patient factors most closely associated with reduced HS complication incidence, as well as identifying effective ways to get patients involved in shared surgical decision‐making.
Extensive resection by way of flaps or skin graft was associated with higher incidence of HS complications. Providers should be cautious when deciding to perform extensive resection or using flaps or skin grafts as a closure technique so as to minimise the risk of adverse events.
FUNDING INFORMATION
This work was supported by Dazhou Science and Technology Bureau, Project number: (2020) S01.
Tang B, Huang Z, Yi Q, Zheng X. Complications of hidradenitis suppurativa after surgical management: A systematic review and meta‐analysis. Int Wound J. 2023;20(4):1253‐1261. doi: 10.1111/iwj.13945
Funding information Dazhou Science and Technology Bureau, Grant/Award Number: (2020) S01
DATA AVAILABILITY STATEMENT
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
REFERENCES
- 1. Wormald JC, Balzano A, Clibbon JJ, Figus A. Surgical treatment of severe hidradenitis suppurativa of the axilla: thoracodorsal artery perforator (TDAP) flap versus split skin graft. J Plast Reconstr Aesthet Surg. 2014;67(8):1118‐1124. [DOI] [PubMed] [Google Scholar]
- 2. Slade DE, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg. 2003;56:451‐461. [DOI] [PubMed] [Google Scholar]
- 3. Saunte DML, Jemec GBE. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA. 2017;318(20):2019‐2032. [DOI] [PubMed] [Google Scholar]
- 4. Parrado R, Cadena M, Vergara A, Cadena D, Chalela JG. The role of negative pressure wound therapy in the management of hidradenitis suppurativa: a case report and literature review. Int Wound J. 2017;14(1):35‐39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Ingram JR, Piguet V. Phenotypic heterogeneity in hidradenitis suppurativa (acne inversa): classification is an essential step toward personalized therapy. J Invest Dermatol. 2013;133:1453‐1456. [DOI] [PubMed] [Google Scholar]
- 6. Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366:158‐164. [DOI] [PubMed] [Google Scholar]
- 7. Kerdel FA. Current and emerging nonsurgical treatment options for hidradenitis suppurativa. Semin Cutan Med Surg. 2014;33(3 suppl):S57‐S59. [DOI] [PubMed] [Google Scholar]
- 8. Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619‐644. [DOI] [PubMed] [Google Scholar]
- 9. Ellis LZ. Hidradenitis suppurativa: surgical and other management techniques. Dermatol Surg. 2012;38:517‐536. [DOI] [PubMed] [Google Scholar]
- 10. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group . Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. Int J Surg. 2010;8:336‐341. [DOI] [PubMed] [Google Scholar]
- 11. Soldin MG, Tulley P, Kaplan H, Hudson DA, Grobbelaar AO. Chronic axillary hidradenitis—the efficacy of wide excision and flap coverage. Br J Plast Surg. 2000;53:434‐436. [DOI] [PubMed] [Google Scholar]
- 12. Rompel R, Petres J. Long‐term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg. 2000;26:638‐643. [DOI] [PubMed] [Google Scholar]
- 13. Kuo HW, Ohara K. Surgical treatment of chronic gluteal hidradenitis suppurativa: reused skin graft technique. Dermatol Surg. 2003;29:173‐178. [DOI] [PubMed] [Google Scholar]
- 14. Civelek B, Aksoy K, Bilgen E, İnal I, Sahin U, Çelebioğlu S. Reconstructive options in severe cases of hidradenitis suppurativa. Cent Eur J Med. 2010;5:674‐678. [Google Scholar]
- 15. van der Zee HH, Prens EP, Boer J. Deroofing: a tissue‐saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63:475‐480. [DOI] [PubMed] [Google Scholar]
- 16. Buyukasik O, Hasdemir AO, Kahramansoy N, Col C, Erkol H. Surgical approach to extensive hidradenitis suppurativa. Dermatol Surg. 2011;37:835‐842. [DOI] [PubMed] [Google Scholar]
- 17. Liu L, Cheng Z, Yu R, Wu Y, et al. Deroofing technique for treatment of perianal hidradenitis suppurativa. Colorectal Anal Surg. 2011;17:320‐322. [Google Scholar]
- 18. Zhang M, Dai Q, Hu C, Chen C, Chen P. Efficacy observation of subctaneous trimming method to 6 cases of axillary hidradenitis suppurativa. Chin J Dermatol Venereol. 2014;28:1288‐1292. [Google Scholar]
- 19. Blok JL, Boersma M, Terra JB, et al. Surgerysurgery under general anaesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients. J Eur Acad Dermatol Venereol. 2015;29:1590‐1597. [DOI] [PubMed] [Google Scholar]
- 20. Chen S, Huang C, Tan M. The effect of different surgical methods in the treatment of large‐area perianal hidradenitis suppurativa. J Guangdong Med Col. 2016;8:428‐431. [Google Scholar]
- 21. Chai M, Yang W, Guo H, Wulan L, Han H. Surgical management of hidradenitis suppurative. Chin J Anaesth Med. 2018;9:45‐48. [Google Scholar]
- 22. Hou J, Wang J, Li D, et al. Treatment of 15 cases of suppurative apocrine adenitis with negative pressure sealing drainage and skin grafting. Chin J Int Med Sur. 2019;25:377‐379. [Google Scholar]
- 23. Du S, Peng T, Xiong Z. Clinical observation on the treatment of perianal suppurative cold bright‐colored by boron bei Jiuhua ointment combined with surgical excision. Dermatol Venereol. 2021;43:266‐267. [Google Scholar]
- 24. Jemec GB. Effect of localized surgical excisions in hidradenitis suppurativa. J Am Acad Dermatol. 1988;18:1103‐1107. [DOI] [PubMed] [Google Scholar]
- 25. Mehdizadeh A, Hazen PG, Bechara FG, et al. Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta‐analysis. J Am Acad Dermatol. 2015;73(5 suppl 1):S70‐S77. [DOI] [PubMed] [Google Scholar]
- 26. Bouazzi D, Chafranska L, Saunte DML, Jemec GBE. Systematic review of complications and recurrences after surgical interventions in hidradenitis suppurativa. Dermatol Surg. 2020;46(7):914‐921. [DOI] [PubMed] [Google Scholar]
- 27. Fertitta L, Hotz C, Wolkenstein P, et al. Efficacy and satisfaction of surgical treatment for hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34(4):839‐845. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
